Combined epigenetic and differentiation-based treatment inhibits neuroblastoma tumor growth and links HIF2α to tumor suppression
Year: 2017
Type: article
Abstract: Significance High-risk neuroblastoma remains a therapeutic challenge, and adjuvant retinoic acid (RA) treatment shows poor efficacy. We demonstrate that combined treatment with 5-Aza-deoxycytidine (AZA) and RA impedes neuroblastoma growth and induces a transcriptional response characterized by high levels of the HIF2α transcription factor. This approach targets high-risk neuroblastoma that responds poorly to RA. In addition, genome-wide analysis of treated tumors and patient data links HIF2α to tumor suppression, which is supported by a HIF2α-specific small molecule inhibitor-mediated block of the tumor response to AZA+RA treatment.
Institutions: Karolinska Institutet, Ludwig Cancer Research
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: bronze
Awards: G1375668453, G2586856532, The role of gene silencing for maintaining cellular identity and tumor suppression in the nervous system, G4070355291, G4507129683, Betydelsen av transkriptionell repression och CHD5 för att motverka uppkomsten av neuroblastom, G6536907729, Betydelsen av hypermetylering och fusionsgener i höggradiga neuroblastom, Rollen för 1p36 genen KIFiBb för tumörsuppression i neuroblastom, G99526243
OpenAlex ID: W2736286144
